In particular, the protein dysregulation of MEX3A was significantly associated with a variety of human malignant tumors, such as in gastric cancer, colorectal cancer, bladder cancer, and pancreatic ductal adenocarcinoma [14, 17, 23–25]. The gene discussed is MEX3A; the disease is urinary bladder carcinoma.